Daesung Microbiological Labs. Co. Ltd
KOSDAQ-listed animal pharmaceutical company producing over 150 veterinary products including vaccines and antibiotics.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1966 and listed on KOSDAQ in 2000, Daesung Microbiological Labs is a veterinary pharmaceutical company. It manufactures and sells over 150 types of animal medicines including vaccines, antibiotics, antimicrobials, dewormers, nutritional supplements, and probiotic enzyme products, and has licensed avian metapneumovirus vaccine (working title: Chicken Pneumo Live Vaccine) manufacturing technology from Carb Inc. while jointly researching an avian adenovirus vaccine (working title: Chicken Adeno2 Chickenvac) with Konkuk University for commercialization. Revenue for the period was approximately KRW 26.0 billion, with domestic sales of KRW 18.7 billion (72%) and exports of KRW 7.3 billion (28%) across eight countries including Pakistan, Vietnam, and Russia.
Products & technology
- Veterinary pharmaceuticals (150+ types including vaccines, antibiotics, antimicrobials, dewormers)Disease prevention and treatment for livestock
R&D and key agreements
Source: DART corporate disclosure닭 뉴모 생백신(가칭) · 조류(닭) 메타뉴모 바이러스 감염증 · 기술이전 완료, 역가증진시험 및 동결건조백신 안정성시험 진행중 · Manufacturing technology licensed from Carb Inc.; royalty paid based on sales volume
닭 아데노2 치큰백(가칭) · 조류(닭) 아데노 바이러스 감염증 · 배양방법 및 역가증진시험 진행중 · Joint research with Konkuk University on commercializing an inactivated avian adenovirus combination vaccine
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition